Fingerprint
Dive into the research topics of 'Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics
Rick Oerlemans, Angel Ruiz Moreno, Ying-Ying Cong, Nilima Dinesh Kumar, M.A. Velasco-Velazquez, Constantinos G. Neochoritis, Jolanda Smit, Fulvio Reggiori, Matthew Groves, Alex Dömling*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
60
Citations
(Scopus)
89
Downloads
(Pure)